Loading…
Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria
This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the h...
Saved in:
| Published in: | American journal of infection control 2012-10, Vol.40 (8), p.776-777 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73 |
| container_end_page | 777 |
| container_issue | 8 |
| container_start_page | 776 |
| container_title | American journal of infection control |
| container_volume | 40 |
| creator | Hamzeh, Abdul Rezzak, BPharm, PhD Al Najjar, Mona, MD, MS Mahfoud, Maysa, MS, PhD |
| description | This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the higher end of globally reported levels. Newer cephalosporins and β-lactamase-resistant agents are becoming practically ineffective. Better activity is limited to carbapenems and colistin, which elicited the highest susceptibility levels. |
| doi_str_mv | 10.1016/j.ajic.2011.09.019 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773823879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196655311012557</els_id><sourcerecordid>1773823879</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73</originalsourceid><addsrcrecordid>eNqFktFqFDEUhoModlt9AS9kQAQvnPEkmSQTEGEptRYKCtVLCdnsGck4M1mTmcK-vRl2baEX9iqQfP9JTr5DyCsKFQUqP3SV7byrGFBaga6A6idkRQVTJWdaPiWrvCNLKQQ_IacpdQCguRTPyQljHERN-Yr8_Bbx1vY4OixCW9hx8hsfJu-KiMmnyS4Hdgjjr2Lt_IhT2Fg3YSw2dh7sOHpf-BR6O2Eq2hiGYt3jbhfeFzf76O0L8qy1fcKXx_WM_Ph88f38S3n99fLqfH1dOgFsKrkACzUwKrVkQqOzzIlaAm90W1NXI2s5aNEyJlA6IRq-lQK55GAl5aj4GXl3qLuL4c-MaTKDTw773o4Y5mSoUrxhvFH6cRQa2igqoc7omwdoF-Y45kYypbmmVOkmU-xAuRhSitiaXfSDjfsMmcWT6cziySyeDGiTreTQ62PpeTPg9i7yT0wG3h4Bm5zt25hF-HTPybpWTMnMfTxwmL_31mM0yfnF5tZHdJPZBv__d3x6EHe9H32-8TfuMd33axIzYG6WiVoGiuaCTAjF_wIeZMLx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1093911798</pqid></control><display><type>article</type><title>Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria</title><source>Elsevier</source><creator>Hamzeh, Abdul Rezzak, BPharm, PhD ; Al Najjar, Mona, MD, MS ; Mahfoud, Maysa, MS, PhD</creator><creatorcontrib>Hamzeh, Abdul Rezzak, BPharm, PhD ; Al Najjar, Mona, MD, MS ; Mahfoud, Maysa, MS, PhD</creatorcontrib><description>This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the higher end of globally reported levels. Newer cephalosporins and β-lactamase-resistant agents are becoming practically ineffective. Better activity is limited to carbapenems and colistin, which elicited the highest susceptibility levels.</description><identifier>ISSN: 0196-6553</identifier><identifier>EISSN: 1527-3296</identifier><identifier>DOI: 10.1016/j.ajic.2011.09.019</identifier><identifier>PMID: 22305413</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Acinetobacter baumannii - drug effects ; Acinetobacter baumannii - isolation & purification ; Acinetobacter Infections - drug therapy ; Acinetobacter Infections - epidemiology ; Acinetobacter Infections - microbiology ; Adolescent ; Adult ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimicrobial agents ; Bacterial diseases ; Bacterial diseases of the urinary system ; Bacterial infections ; Biological and medical sciences ; Carbapenems ; Carbapenems - pharmacology ; Carbapenems - therapeutic use ; Child ; Child, Preschool ; Colistin ; Colistin - pharmacology ; Colistin - therapeutic use ; Drug resistance ; Drug Resistance, Multiple, Bacterial ; Epidemiology. Vaccinations ; General aspects ; Gram-negative bacteria ; Human bacterial diseases ; Humans ; Infant ; Infection Control ; Infectious Disease ; Infectious diseases ; Medical sciences ; Medical treatment ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Prevalence ; Respiratory infections ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - epidemiology ; Respiratory Tract Infections - microbiology ; Retrospective Studies ; Syria - epidemiology ; Urinary infections ; Urinary Tract Infections - drug therapy ; Urinary Tract Infections - epidemiology ; Urinary Tract Infections - microbiology ; Young Adult</subject><ispartof>American journal of infection control, 2012-10, Vol.40 (8), p.776-777</ispartof><rights>Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>2012 Association for Professionals in Infection Control and Epidemiology, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.</rights><rights>Copyright Mosby-Year Book, Inc. Oct 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73</citedby><cites>FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26447276$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22305413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamzeh, Abdul Rezzak, BPharm, PhD</creatorcontrib><creatorcontrib>Al Najjar, Mona, MD, MS</creatorcontrib><creatorcontrib>Mahfoud, Maysa, MS, PhD</creatorcontrib><title>Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria</title><title>American journal of infection control</title><addtitle>Am J Infect Control</addtitle><description>This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the higher end of globally reported levels. Newer cephalosporins and β-lactamase-resistant agents are becoming practically ineffective. Better activity is limited to carbapenems and colistin, which elicited the highest susceptibility levels.</description><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter baumannii - isolation & purification</subject><subject>Acinetobacter Infections - drug therapy</subject><subject>Acinetobacter Infections - epidemiology</subject><subject>Acinetobacter Infections - microbiology</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimicrobial agents</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the urinary system</subject><subject>Bacterial infections</subject><subject>Biological and medical sciences</subject><subject>Carbapenems</subject><subject>Carbapenems - pharmacology</subject><subject>Carbapenems - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Colistin</subject><subject>Colistin - pharmacology</subject><subject>Colistin - therapeutic use</subject><subject>Drug resistance</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Gram-negative bacteria</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infection Control</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>Respiratory infections</subject><subject>Respiratory Tract Infections - drug therapy</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Retrospective Studies</subject><subject>Syria - epidemiology</subject><subject>Urinary infections</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urinary Tract Infections - epidemiology</subject><subject>Urinary Tract Infections - microbiology</subject><subject>Young Adult</subject><issn>0196-6553</issn><issn>1527-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFktFqFDEUhoModlt9AS9kQAQvnPEkmSQTEGEptRYKCtVLCdnsGck4M1mTmcK-vRl2baEX9iqQfP9JTr5DyCsKFQUqP3SV7byrGFBaga6A6idkRQVTJWdaPiWrvCNLKQQ_IacpdQCguRTPyQljHERN-Yr8_Bbx1vY4OixCW9hx8hsfJu-KiMmnyS4Hdgjjr2Lt_IhT2Fg3YSw2dh7sOHpf-BR6O2Eq2hiGYt3jbhfeFzf76O0L8qy1fcKXx_WM_Ph88f38S3n99fLqfH1dOgFsKrkACzUwKrVkQqOzzIlaAm90W1NXI2s5aNEyJlA6IRq-lQK55GAl5aj4GXl3qLuL4c-MaTKDTw773o4Y5mSoUrxhvFH6cRQa2igqoc7omwdoF-Y45kYypbmmVOkmU-xAuRhSitiaXfSDjfsMmcWT6cziySyeDGiTreTQ62PpeTPg9i7yT0wG3h4Bm5zt25hF-HTPybpWTMnMfTxwmL_31mM0yfnF5tZHdJPZBv__d3x6EHe9H32-8TfuMd33axIzYG6WiVoGiuaCTAjF_wIeZMLx</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Hamzeh, Abdul Rezzak, BPharm, PhD</creator><creator>Al Najjar, Mona, MD, MS</creator><creator>Mahfoud, Maysa, MS, PhD</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Mosby-Year Book, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20121001</creationdate><title>Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria</title><author>Hamzeh, Abdul Rezzak, BPharm, PhD ; Al Najjar, Mona, MD, MS ; Mahfoud, Maysa, MS, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter baumannii - isolation & purification</topic><topic>Acinetobacter Infections - drug therapy</topic><topic>Acinetobacter Infections - epidemiology</topic><topic>Acinetobacter Infections - microbiology</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimicrobial agents</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the urinary system</topic><topic>Bacterial infections</topic><topic>Biological and medical sciences</topic><topic>Carbapenems</topic><topic>Carbapenems - pharmacology</topic><topic>Carbapenems - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Colistin</topic><topic>Colistin - pharmacology</topic><topic>Colistin - therapeutic use</topic><topic>Drug resistance</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Gram-negative bacteria</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infection Control</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>Respiratory infections</topic><topic>Respiratory Tract Infections - drug therapy</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Retrospective Studies</topic><topic>Syria - epidemiology</topic><topic>Urinary infections</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urinary Tract Infections - epidemiology</topic><topic>Urinary Tract Infections - microbiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamzeh, Abdul Rezzak, BPharm, PhD</creatorcontrib><creatorcontrib>Al Najjar, Mona, MD, MS</creatorcontrib><creatorcontrib>Mahfoud, Maysa, MS, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>American journal of infection control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamzeh, Abdul Rezzak, BPharm, PhD</au><au>Al Najjar, Mona, MD, MS</au><au>Mahfoud, Maysa, MS, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria</atitle><jtitle>American journal of infection control</jtitle><addtitle>Am J Infect Control</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>40</volume><issue>8</issue><spage>776</spage><epage>777</epage><pages>776-777</pages><issn>0196-6553</issn><eissn>1527-3296</eissn><abstract>This study describes and analyzes Acinetobacter baumannii antibiotic susceptibly profile in Aleppo, Syria, thus providing vital information for guiding treatment of A baumannii infections. Two hundred sixty nonrepetitive A baumannii isolates were studied over 3.5 years. Resistance rates are at the higher end of globally reported levels. Newer cephalosporins and β-lactamase-resistant agents are becoming practically ineffective. Better activity is limited to carbapenems and colistin, which elicited the highest susceptibility levels.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>22305413</pmid><doi>10.1016/j.ajic.2011.09.019</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0196-6553 |
| ispartof | American journal of infection control, 2012-10, Vol.40 (8), p.776-777 |
| issn | 0196-6553 1527-3296 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1773823879 |
| source | Elsevier |
| subjects | Acinetobacter baumannii - drug effects Acinetobacter baumannii - isolation & purification Acinetobacter Infections - drug therapy Acinetobacter Infections - epidemiology Acinetobacter Infections - microbiology Adolescent Adult Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Antimicrobial agents Bacterial diseases Bacterial diseases of the urinary system Bacterial infections Biological and medical sciences Carbapenems Carbapenems - pharmacology Carbapenems - therapeutic use Child Child, Preschool Colistin Colistin - pharmacology Colistin - therapeutic use Drug resistance Drug Resistance, Multiple, Bacterial Epidemiology. Vaccinations General aspects Gram-negative bacteria Human bacterial diseases Humans Infant Infection Control Infectious Disease Infectious diseases Medical sciences Medical treatment Microbial Sensitivity Tests Pharmacology. Drug treatments Prevalence Respiratory infections Respiratory Tract Infections - drug therapy Respiratory Tract Infections - epidemiology Respiratory Tract Infections - microbiology Retrospective Studies Syria - epidemiology Urinary infections Urinary Tract Infections - drug therapy Urinary Tract Infections - epidemiology Urinary Tract Infections - microbiology Young Adult |
| title | Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A55%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20antibiotic%20resistance%20among%20Acinetobacter%20baumannii%20isolates%20from%20Aleppo,%20Syria&rft.jtitle=American%20journal%20of%20infection%20control&rft.au=Hamzeh,%20Abdul%20Rezzak,%20BPharm,%20PhD&rft.date=2012-10-01&rft.volume=40&rft.issue=8&rft.spage=776&rft.epage=777&rft.pages=776-777&rft.issn=0196-6553&rft.eissn=1527-3296&rft_id=info:doi/10.1016/j.ajic.2011.09.019&rft_dat=%3Cproquest_cross%3E1773823879%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-350a04021696259eca2c5460389f41c4e2f3095f225e6c5583d65e3630a613e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1093911798&rft_id=info:pmid/22305413&rfr_iscdi=true |